Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 211Triple Negative Breast Neoplasms 32Inflammatory Breast Neoplasms 21Breast Neoplasms, Male 5Primary Breast Cancer 3Neoplasms 3Carcinoma, Ductal, Breast 3Pathologic Complete Response 2HER2-negative Breast Cancer 2Cardiotoxicity 2Breast Diseases 2Women With Primary Breast Cancer 1Unilateral HER2 Positive Breast Cancer 1Sarcoma 1Resectable HER2-positive Breast Cancer 1Postoperative Complications 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Neoadjuvant Operable Breast Cancer 1Kenny-Caffey syndrome, Type 1 1Hormone Receptor Positive HER-2 Negative Breast Cancer 1Her2-Positive Breast Cancer 1HR-positive,HER2-negative Breast Cancer 1HR+/HER2- Breast Cancer 1HER2-negative Early Breast Cancer 1HER2 Positive Early Breast Cancer 1

Interventions

Docetaxel 4Epirubicin 3Cyclophosphamide 3Paclitaxel 2Vinorelbine 1Tamoxifen 1Iodine-123 1Fluorouracil 1Doxorubicin 1Carboplatin 1CP protocol 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Primary Breast Cancer × Epirubicin × Breast × Clear all
NCT04127019 2020-02-26

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

Fudan University

Phase 3 Completed
2,079 enrolled
Breast

Primary Breast Cancer

NCT01049425 2019-08-14

planB

West German Study Group

Phase 3 Completed
3,198 enrolled
Breast

Primary Breast Cancer

NCT00527449 2010-01-15

ETCat01

Klinikum Weissenfels

Phase 2 Completed
50 enrolled
Breast

Primary Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡